Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
BMJ Open|June 9, 2017
Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)Kristine Færch, Hanan Amadid, Lea Bruhn Nielsen, et al.
Plos One|July 30, 2021
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetesElisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, et al.
Diabetes, Obesity & Metabolism|October 22, 2021
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trialsEmilie H Zobel, Bernt Johan von Scholten, Tine W Hansen, et al.
Journal of Diabetes and Its Complications|August 13, 2023
Risk of atrial fibrillation in individuals with dysglycemia and diabetesRasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, et al.
Diabetes, Obesity & Metabolism|September 18, 2023
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled studySuvanjaa Sivalingam, Victor Soendergaard Wasehuus, Viktor Rotbain Curovic, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) studyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Qualitative Health Research|January 6, 2024
"I Haven't Told Anyone but You": Experiences and Biopsychosocial Support Needs of People With Type 2 Diabetes and Binge EatingPil Lindgreen, Ingrid Willaing, Loa Clausen, et al.
Kidney International Reports|December 19, 2024
Prognosis for Type 1 Diabetes with Diabetic Nephropathy between 2000 and 2020 - Changes in Kidney Function Decline Over Time and Development of Cardiovascular Disease, Kidney Failure, and MortalityChristina G Poulsen, Kristin Jesse, Bendix Carstensen, et al.
Journal of Diabetes and Its Complications|December 21, 2024
Bone mineral density and the risk of kidney disease in patients with type 1 diabetesSabina Chaudhary Hauge, Henrik Øder Hjortkjær, Frederik Persson, et al.
Diabetes, Obesity & Metabolism|June 30, 2021
A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort studyHanan Amadid, Pernille F Rønn, Maria Bekker-Nielsen Dunbar, et al.
Pageof 16